Rel-Atorvastatin rel-(3R,5R)-7-(2-(4-氟苯基)-5-异丙基-3-苯基-4-(苯基氨基甲酰基)-1H-吡咯-1-基)-3,5-二羟基庚酸
CAS 110862-48-1 MFCD00899261
化学结构图
SMILES: CC(C)C1=C(C(=C(C2C=CC(F)=CC=2)N1CC[C@@H](O)C[C@@H](O)CC(O)=O)C1C=CC=CC=1)C(=O)NC1C=CC=CC=1 |&1:17,20|
化学属性
| Mol. Formula | C33H35FN2O5 |
|---|---|
| Mol. Weight | 558.66 |
别名和识别编码
| Chemical Name | Rel-Atorvastatin |
|---|---|
| CAS Number | 134523-00-5 |
| Alfabeta Name | FLUOROPHENYLISOPROPYLPHENYLPHENYLCARBAMOYLPYRROLYLDIHYDROXYHEPTANOICACID RRH357245341135(((())))----------------,, |
| MDL Number | MFCD00899261 |
| LabNetwork Molecule ID | LN00173731 |
| Chemical Name Translation | rel-(3R,5R)-7-(2-(4-氟苯基)-5-异丙基-3-苯基-4-(苯基氨基甲酰基)-1H-吡咯-1-基)-3,5-二羟基庚酸 |
信息真实价格透明
资金保障
专业采购外包团队在线服务
信息真实价格透明
资金保障
专业采购外包团队在线服务
品牌质保精细包装
现货库存
一流品牌服务
相关文献及参考
- [2]. Turner NA, et al. Comparison of the efficacies of five different statins on inhibition of human saphenous vein smooth muscle cell proliferation and invasion. J Cardiovasc Pharmacol. 2007 Oct;50(4):458-61.
- [3]. Nawrocki, J.W., et al., Reduction of LDL cholesterol by 25% to 60% in patients with primary hypercholesterolemia by atorvastatin, a new HMG-CoA reductase inhibitor. Arterioscler Thromb Vasc Biol, 1995. 15(5): p. 678-82.
- [4]. Ming-Bai Hu, et al. Atorvastatin induces autophagy in MDA-MB-231 breast cancer cells. Ultrastruct Pathol. Sep-Oct 2018;42(5):409-415.
- [1]. Santodomingo-Garzón T, et al. Atorvastatin inhibits inflammatory hypernociception. Br J Pharmacol. 2006 Sep;149(1):14-22.
- [1]. Santodomingo-Garzón T, et al. Atorvastatin inhibits inflammatory hypernociception. Br J Pharmacol. 2006 Sep;149(1):14-22.
- [2]. Turner NA, et al. Comparison of the efficacies of five different statins on inhibition of human saphenous vein smo
京ICP备2020036287号